Sapio Sciences, the science-aware™ lab informatics platform, today announced the Sapio Partner Program.
FDA Expands Approval of Ribociclib to Early Breast Cancer
The FDA on Tuesday approved ribociclib (Kisqali) in combination with endocrine therapy as adjuvant treatment for early high-risk breast cancer. Already approved in the metastatic